TY - JOUR
T1 - Obesity-associated breast inflammation among Hispanic/Latina breast cancer patients
AU - Greenlee, Heather
AU - Shi, Zaixing
AU - Hibshoosh, Hanina
AU - Giri, Dilip D.
AU - Ahmed, Aqeel
AU - Williams, Samantha
AU - Falcone, Domenick J.
AU - Winston, Lisle A.
AU - Zhou, Xi K.
AU - Hudis, Clifford A.
AU - Hershman, Dawn L.
AU - Dannenberg, Andrew
AU - Iyengar, Neil M.
N1 - Funding Information:
We thank study participants for donating their tissue samples for research. We also thank Saiful Lughmani for providing preoperative weight and height data, and Kathleene Ulanday for her work in abstracting clinical data. This study was supported by the Herbert Irving Comprehensive Cancer Center Core/Support Grant (P30 CA013696), Breast Cancer Research Foundation, the Conquer Cancer Foundation of the American Society of Clinical Oncology, Myrna and Bernard Posner, the Fishman Family Foundation, Kat's Ribbon of Hope, the Botwinick-Wolfensohn Foundation (in memory of Mr. and Mrs. Benjamin Botwinick), NIH/NCI U54 CA210184-01, the Transdisciplinary Research on Energetics and Cancer Training Workshop (R25CA203650), and the Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA008748).
Funding Information:
We thank study participants for donating their tissue samples for research. We also thank Saiful Lughmani for providing preoperative weight and height data, and Kathleene Ulanday for her work in abstracting clinical data. This study was supported by the Herbert Irving Comprehensive Cancer Center Core/Support Grant (P30 CA013696), Breast Cancer Research Foundation, the Conquer Cancer Foundation of the American Society of Clinical Oncology, Myrna and Bernard Posner, the Fishman Family Foundation, Kat's Ribbon of
Publisher Copyright:
©2018 American Association for Cancer Research.
PY - 2019/1
Y1 - 2019/1
N2 - Breast white adipose tissue inflammation (BWATi) is associated with obesity and higher breast cancer risk among non-Hispanic white women. Obesity is prevalent in Hispanic/Latina patients with breast cancer, and the occurrence of BWATi in this population is not well-characterized. The association between BWATi and body mass index (BMI) was evaluated in Hispanic/ Latina patients with breast cancer who underwent mastectomy. BWATi was defined as the presence of crown-like structures of the breast (CLS-B), detected by CD68 IHC in nontumor breast tissue. BWATi severity was quantified as number of CLS-B/cm 2 . Adipocyte diameter was measured using hematoxylin and eosin-stained breast tissue sections. Preoperative BMI (within 1 week prior to mastectomy) was categorized as normal (18.5–<25.0 kg/m 2 ), overweight (25.0–<30.0 kg/m 2 ), class I obesity (30.0–<35.0 kg/m 2 ), and class II–III obesity (35.0 kg/m 2 or above). Patient charts were abstracted to record clinicopathologic features and liver function tests <90 days before mastectomy. The study included 91 women (mean age 69 years; range 36–96 years). Prevalence of BWATi increased with BMI (24% in normal weight, 34% in overweight, 57% in class I obesity, and 65% in class II–III obesity; P trend <0.01). Severe BWATi (>0.27 CLS-B/cm 2 ) was associated with higher BMI (P trend ¼ 0.046) and greater adipocyte diameter (P ¼ 0.04). Adjusting for BMI, neoadjuvant chemotherapy, and elevated alanine aminotransferase were associated with severe BWATi, and current smoking was associated with mild BWATi (all P < 0.05). BWATi was associated with higher BMI in Hispanic/Latina patients with breast cancer, consistent with previously described associations in other populations.
AB - Breast white adipose tissue inflammation (BWATi) is associated with obesity and higher breast cancer risk among non-Hispanic white women. Obesity is prevalent in Hispanic/Latina patients with breast cancer, and the occurrence of BWATi in this population is not well-characterized. The association between BWATi and body mass index (BMI) was evaluated in Hispanic/ Latina patients with breast cancer who underwent mastectomy. BWATi was defined as the presence of crown-like structures of the breast (CLS-B), detected by CD68 IHC in nontumor breast tissue. BWATi severity was quantified as number of CLS-B/cm 2 . Adipocyte diameter was measured using hematoxylin and eosin-stained breast tissue sections. Preoperative BMI (within 1 week prior to mastectomy) was categorized as normal (18.5–<25.0 kg/m 2 ), overweight (25.0–<30.0 kg/m 2 ), class I obesity (30.0–<35.0 kg/m 2 ), and class II–III obesity (35.0 kg/m 2 or above). Patient charts were abstracted to record clinicopathologic features and liver function tests <90 days before mastectomy. The study included 91 women (mean age 69 years; range 36–96 years). Prevalence of BWATi increased with BMI (24% in normal weight, 34% in overweight, 57% in class I obesity, and 65% in class II–III obesity; P trend <0.01). Severe BWATi (>0.27 CLS-B/cm 2 ) was associated with higher BMI (P trend ¼ 0.046) and greater adipocyte diameter (P ¼ 0.04). Adjusting for BMI, neoadjuvant chemotherapy, and elevated alanine aminotransferase were associated with severe BWATi, and current smoking was associated with mild BWATi (all P < 0.05). BWATi was associated with higher BMI in Hispanic/Latina patients with breast cancer, consistent with previously described associations in other populations.
UR - http://www.scopus.com/inward/record.url?scp=85059797817&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059797817&partnerID=8YFLogxK
U2 - 10.1158/1940-6207.CAPR-18-0207
DO - 10.1158/1940-6207.CAPR-18-0207
M3 - Article
C2 - 30404870
AN - SCOPUS:85059797817
VL - 12
SP - 21
EP - 30
JO - Cancer Prevention Research
JF - Cancer Prevention Research
SN - 1940-6207
IS - 1
ER -